These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 14087455)

  • 21. [ON THE DETERMINATION OF THE NEUROVIRULENCE OF LIVE POLIOVIRUS VACCINES. II. PATHOMORPHOLOGY OF APE POLIOMYELITIS CAUSED BY ATTENUATED POLIOVIRUSES AFTER INTRALUMBAR INJECTION WITH SPECIAL REFERENCE TO DIFFERENCES BETWEEN THE VIRUS TYPES].
    UNTERHARNSCHEIDT F; BONIN O
    Arch Psychiatr Nervenkr; 1965 Mar; 206():454-73. PubMed ID: 14271779
    [No Abstract]   [Full Text] [Related]  

  • 22. STUDIES ON THE SALK AND LIVE ATTENUATED POLIOVIRUS VACCINE.
    NISHIZAWA Y; KODAMA T; MAJIMA E; ARAKI M; CHIN S
    Biken J; 1963 Jul; 6():97-110. PubMed ID: 14147708
    [No Abstract]   [Full Text] [Related]  

  • 23. EXPERIENCE IN THE ADMINISTRATION OF LIVE ATTENUATED POLIOVIRUS VACCINE (SABIN) IN INFANTS, WITH REFERENCE TO THE RELATION BETWEEN POLIO AND NON-POLIO VIRUSES.
    KONISHI S; SASATANI M; HAYAKAWA Y; KUROSE T; ASHIHARA Y
    Shonika Kiyo; 1963; 9():283-96. PubMed ID: 14112921
    [No Abstract]   [Full Text] [Related]  

  • 24. Community spread of orally administered attenuated poliovirus vaccine strains.
    KIMBALL AC; BARR RN; BAUERH ; KLEINMANH ; JOHNSON EA; COONEY MK
    Public Health Rep (1896); 1961 Oct; 76(10):903-14. PubMed ID: 14455990
    [No Abstract]   [Full Text] [Related]  

  • 25. EPIDEMIOLOGICAL ASPECTS OF COXSACKIE AND ECHO VIRUS INFECTIONS IN TROPICAL AREAS.
    FOX JP
    Am J Public Health Nations Health; 1964 Jul; 54(7):1134-42. PubMed ID: 14157847
    [No Abstract]   [Full Text] [Related]  

  • 26. POLIOVIRUS SHEDDING AND SEROCONVERSION. STUDIES OF 816 COSTA RICAN CHILDREN FED TRIVALENT VACCINE.
    ROCA-GARCIA M; MARKHAM FS; COX HR; VARGAS-MENDEZ O; GUEVARA EC; MONTOYA JA
    JAMA; 1964 May; 188():639-46. PubMed ID: 14121285
    [No Abstract]   [Full Text] [Related]  

  • 27. THE USE OF A MODIFIED WECKER TECHNIQUE FOR SERODIFFERENTIATION OF TYPE 1 POLIOVIRUSES RELATED AND UNRELATED TO SABIN'S VACCINE STRAIN. II. ANTIGENIC SEGREGATION OF ISOLATES FROM SPECIMENS COLLECTED IN FIELD STUDIES.
    NAKANO JH; GELFAND HM; COLE JT
    Am J Hyg; 1963 Sep; 78():214-26. PubMed ID: 14063724
    [No Abstract]   [Full Text] [Related]  

  • 28. Role of live attenuated poliovirus vaccine.
    SKINNER RG
    J Fla Med Assoc (1914); 1960 May; 46():1387-9. PubMed ID: 13831482
    [No Abstract]   [Full Text] [Related]  

  • 29. [Studies on the oral administration of live attenuated poliovirus vaccine in the monkey].
    KAMBARA Y
    Virus; 1961 Oct; 11():333-49. PubMed ID: 14453401
    [No Abstract]   [Full Text] [Related]  

  • 30. Measurement of the protective effect of attenuated poliovirus vaccine.
    KNOWELDEN J; HALE JH; GARDNER PS; LEE LH
    Br Med J; 1961 May; 1(5237):1418-20. PubMed ID: 13757211
    [No Abstract]   [Full Text] [Related]  

  • 31. A phase contrast microprecipitin test with poliovirus antigens. II. Occurrence and development of microprecipitin antibody after natural inapparent infections, after inoculation of Salk vaccine, after feeding of attenuated live poliovirus vaccine, and in disease caused by polioviruses and other enteroviruses.
    EGGERS HJ; SABIN AB
    Arch Gesamte Virusforsch; 1961; 11():152-75. PubMed ID: 13725917
    [No Abstract]   [Full Text] [Related]  

  • 32. Immunization with live attenuated poliovirus vaccine.
    KRUGMAN S; WARREN J; EIGER MS; BERMAN PH; MICHAELS RM; SABIN AB
    Am J Dis Child; 1961 Jan; 101():23-9. PubMed ID: 13754588
    [No Abstract]   [Full Text] [Related]  

  • 33. Properties and behavior of orally administered attenuated poliovirus vaccine.
    SABIN AB
    J Am Med Assoc; 1957 Jul; 164(11):1216-23. PubMed ID: 13438685
    [No Abstract]   [Full Text] [Related]  

  • 34. Response of Cuban children to oral vaccination with living attenuated poliovirus vaccines. A clinical and serological study.
    EMBIL J
    Br Med J; 1960 Apr; 1(5180):1157-62. PubMed ID: 13820150
    [No Abstract]   [Full Text] [Related]  

  • 35. Status of field trials with an orally administered, live attenuated poliovirus vaccine.
    SABIN AB
    J Am Med Assoc; 1959 Oct; 171():863-8. PubMed ID: 14440556
    [No Abstract]   [Full Text] [Related]  

  • 36. [Immunologic protection against the contamination of antipoliomyelitis vaccines by oncogenic viruses].
    BARSKI G
    C R Hebd Seances Acad Sci; 1963 Apr; 256():3776-8. PubMed ID: 13969610
    [No Abstract]   [Full Text] [Related]  

  • 37. Proposed method and evaluation of the monkey neurovirulence test for attenuated poliovirus vaccine.
    JUNGHERR EL; CABASSO VJ; MOYER AW; COX HR
    J Infect Dis; 1961; 108():247-61. PubMed ID: 13791071
    [No Abstract]   [Full Text] [Related]  

  • 38. [SEROLOGICAL AND VIROLOGICAL STUDIES ON THE VACCINATION OF ATTENUATED LIVE POLIOVIRUS VACCINE].
    KIDA T; HARADA Y; TOMITA Y
    Kumamoto Igakkai Zasshi; 1963 Sep; 37():543-53 CO. PubMed ID: 14090753
    [No Abstract]   [Full Text] [Related]  

  • 39. CHARACTERISTICS OF SABIN TYPE 1 POLIOVIRUS AFTER GASTROINTESTINAL PASSAGE IN NEWBORN INFANTS. II. ANTIGENICITY AND ELUTION FROM AL(OH)3 GEL.
    WOODS WA; ROBBINS FC; WEISS RA; CASHEL J; KIRSCHSTEIN RL
    Am J Hyg; 1964 Mar; 79():236-44. PubMed ID: 14131876
    [No Abstract]   [Full Text] [Related]  

  • 40. Interference patterns encountered when using attenuated poliovirus vaccines.
    HALE JH; LEE LH; GARDNER PS
    Br Med J; 1961 Sep; 2(5254):728-32. PubMed ID: 13710702
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.